Dianthus Therapeutics (DNTH) Other Non-Current Assets (2017 - 2025)

Dianthus Therapeutics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $9.7 million for Q4 2025.

• In Q4 2025, Other Non-Current Assets rose 0.9% year-over-year to $9.7 million; the TTM figure through Dec 2025 stood at $9.7 million (up 0.9% YoY), while the FY2025 annual figure was $9.7 million, up 0.9% from the prior year.
• Other Non-Current Assets was $9.7 million for Q4 2025 at Dianthus Therapeutics, up from $167000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $9.7 million in Q4 2025 to a low of $60000.0 in Q3 2022.
• Historically, Other Non-Current Assets has averaged $2.1 million across 5 years, with a median of $692500.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets sank 96.63% in 2022, then soared 13810.61% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $1.8 million in 2021, then slumped by 96.63% to $60000.0 in 2022, then jumped by 1823.33% to $1.2 million in 2023, then jumped by 734.4% to $9.6 million in 2024, then advanced by 0.9% to $9.7 million in 2025.
• The last three Other Non-Current Assets figures came in at $9.7 million (Q4 2025), $167000.0 (Q3 2025), and $9.2 million (Q2 2025), per Business Quant data.